Achieving Optimal Particle Size Distribution in Inhalation Therapy

Bruno, Bob
April 2007
Medical Design Technology;Apr2007, Vol. 11 Issue 4, pS6
Trade Publication
The article deals with the concerns of medical device manufacturers and their pharmaceutical partners over their attempt to achieve the correct size for an inhalation device in the U.S. One of the challenges faced by manufacturers regarding the making of inhalation therapy is the effect of size particle on the effectiveness of the device. Another concern raised by makers is the formulation of the medication and the function of the inhaler device.


Related Articles

  • The Future of Metered-Dose Inhalers. Pritchard, John // Pharmaceutical Technology Europe;Sep2005, Vol. 17 Issue 9, p22 

    Advances in pressurized metered-dose inhalers (pMDIs) in terms of formulation capability and the performance of the container closure system enable products to be developed faster and with less technical risk. Despite new delivery devices for new molecules breaking into the pMDI market, pMDIs...

  • Control particle size and morphology with this technique.  // Chemical Engineering;Oct2013, Vol. 120 Issue 10, p12 

    The article reports on the development of an antisolvent vapor precipitation (AVP) technique as of October 2013, for the control of lactose particle size and morphology, which may improve the efficiency of powder pulmonary-drug delivery, as in the case of asthma inhalers.

  • Methods of delivering drugs. Rees, John // BMJ: British Medical Journal (International Edition);9/3/2005, Vol. 331 Issue 7515, p504 

    Focuses on different types of medical devices used to administer drugs through inhalation to patients. Description of several inhalers, including metered does, CFC-free, spacer and dry powder; Nebulisers, tablets, syrups and injections; How these devices work to deliver medication.

  • Pfizer dumps Exubera. Mack, George S. // Nature Biotechnology;Dec2007, Vol. 25 Issue 12, p1331 

    The article discusses on the abandonement of exubera, an inhaled powder insulin product of Pfizer Inc, after 11 years of development and barely one full year of sales. The development of exubera was a massive technical achievement, involving the stabilization of the insulin molecule to make it...

  • Dry powder inhalers: challenges and goals for next generation therapies. Hak-Kim CHan; Young, Paul M.; Traini, Daniela; Coates, Matthew // Pharmaceutical Technology Europe;Apr2007, Vol. 19 Issue 4, p19 

    This article describes the latest developments in dry powder inhaler (DPI) systems, including the nature and production of active pharmaceutical ingredient particles, formulation considerations for powder blends, and recent developments in DPI devices.

  • CFC-FREE INHALERS. Haggerty, Sharon // Practice Nurse;4/9/2004, Vol. 27 Issue 7, p48 

    Examines the transition of chlorofluorocarbon (CFC) inhalers to CFC-free versions. Results of a survey on the awareness of respiratory patients at Sunderland Royal Hospital on the CFC issue; Advantages of medication transition; Models for transition of existing patients.

  • Inhalation devices and propellants.  // CMAJ: Canadian Medical Association Journal;11/30/99 Supplement, Vol. 161, pS44 

    The article focuses on the recommendations for the use of inhalation devices and propellants for asthma in children and adults. The article offers guidelines for the use of inhalation devices including pressurized metered-dose inhalers, metered-dose inhalers with spacers, dry-powder inhalers and...

  • BREATHE RIGHT VAPOR SHOT! Haar, Kristina // Joe Weider's Muscle & Fitness;Nov2003, Vol. 64 Issue 11, p38 

    Provides information on the Breathe Right Vapor Shot! personal vaporizer. Advantages over other sinusitis or allergy solutions; Cost.

  • Dry Powder Inhalers: Which Factors Determine the Frequency of Handling Errors? Wieshammer, Siegfried; Dreyhaupt, Jens // Respiration;2008, Vol. 75 Issue 1, p18 

    Background: Dry powder inhalers are often used ineffectively, resulting in a poor level of disease control. Objectives: To determine how often essential mistakes are made in the use of Aerolizer®, Discus®, HandiHaler® and Turbuhaler® and to study the effects of age, severity of...

  • Dry Powder Inhalers and the Risk of Error. Terzano, Claudio // Respiration;2008, Vol. 75 Issue 1, p14 

    The article addresses the issue of potential errors in using dry powder inhalers (DPI). According to the author, a substantial proportion of patients handle their inhalers poorly. The author states that DPIs need further technological development in order to release, independently of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics